158 related articles for article (PubMed ID: 11041825)
21. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
[TBL] [Abstract][Full Text] [Related]
22. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B.
Albarran B; Goncalves L; Salmen S; Borges L; Fields H; Soyano A; Montes H; Berrueta L
APMIS; 2005; 113(7-8):526-35. PubMed ID: 16086823
[TBL] [Abstract][Full Text] [Related]
23. [The evaluation on immunogenicity of hepatitis B vaccine].
Li HM; Liang ZL; Zhang HY
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):378-81. PubMed ID: 15231155
[No Abstract] [Full Text] [Related]
24. Nephrotic syndrome after recombinant hepatitis B vaccine.
Macário F; Freitas L; Correia J; Campos M; Marques A
Clin Nephrol; 1995 May; 43(5):349. PubMed ID: 7634556
[No Abstract] [Full Text] [Related]
25. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
[TBL] [Abstract][Full Text] [Related]
26. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults.
Estévez ZC; Betancourt AA; Muzio González V; Baile NF; Silva CV; Bernal FH; Arias EP; Delhanty Fernández A; Olazábal NM; del Río Martín A; Batista LL; Véliz Ríos G; Hernández HH; Hernández AB; Lugo EP; de la Torre Cruz J; Batista Marchec BL; Falcón LA; Brito JT; León DO; Saura PL
Biologicals; 2007 Apr; 35(2):115-22. PubMed ID: 17056272
[TBL] [Abstract][Full Text] [Related]
28. Vaccination against hepatitis B in patients on chronic hemodialysis.
Kovacic V; Sain M; Vukman V
Saudi Med J; 2003 Mar; 24(3):311. PubMed ID: 12704514
[No Abstract] [Full Text] [Related]
29. Hepatitis B vaccines: use in childhood.
Moyes CD
N Z Med J; 1988 Apr; 101(843):165-6. PubMed ID: 2965800
[No Abstract] [Full Text] [Related]
30. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
Ristola MA; Vuola JM; Valle M; von Reyn CF
Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
[TBL] [Abstract][Full Text] [Related]
31. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
Campos Nizama J
Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
[TBL] [Abstract][Full Text] [Related]
32. A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.
Dupont J; Altclas J; Lepetic A; Lombardo M; Vázquez V; Salgueira C; Seigelchifer M; Arndtz N; Antunez E; von Eschen K; Janowicz Z
Vaccine; 2006 Nov; 24(49-50):7167-74. PubMed ID: 16884836
[TBL] [Abstract][Full Text] [Related]
33. [A case of intense cytolysis following the administration of a hepatitis B vaccine].
Lasheras Carbajo MD; Palacios Díez M; González Diego P; Martín Scapa MA; Cano Ruiz A; Asensio Vegas A
Rev Clin Esp; 1999 Jan; 199(1):49-50. PubMed ID: 10089783
[No Abstract] [Full Text] [Related]
34. Plasma-derived and recombinant hepatitis B vaccines.
John TJ
Indian Pediatr; 1997 Aug; 34(8):745-6. PubMed ID: 9492408
[No Abstract] [Full Text] [Related]
35. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with recombinant HBsAg-HBIG complex in healthy adults.
Xu DZ; Huang KL; Zhao K; Xu LF; Shi N; Yuan ZH; Wen YM
Vaccine; 2005 Apr; 23(20):2658-64. PubMed ID: 15780449
[TBL] [Abstract][Full Text] [Related]
37. Clinical safety and efficacy of first indigenous recombinant hepatitis B vaccine.
Kumar A; Joshi N; Sreenivas DV; Palan S; Nagarjuna Kumar YR
J Assoc Physicians India; 1998 Jul; 46(7):620-2. PubMed ID: 12152846
[TBL] [Abstract][Full Text] [Related]
38. The study of immune effect of nine kinds of recombinant hepatitis B vaccines made in China and foreign countries.
Jing Q; Ren L; Wang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):349-51. PubMed ID: 11471023
[TBL] [Abstract][Full Text] [Related]
39. Adverse reaction to the recombinant hepatitis B vaccine.
Hudson TJ; Newkirk M; Gervais F; Shuster J
J Allergy Clin Immunol; 1991 Nov; 88(5):821-2. PubMed ID: 1835467
[No Abstract] [Full Text] [Related]
40. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
